Biome Diagnostics

📍 Vienna, Austria🗓 Founded 2018👥 13 employees💰 Last funded Dec 2022
Biotechnology Research🌐 biome-dx.com
Website LinkedIn
Biome Diagnostics GmbH (BiomeDx®) is an Austrian based MedTech company committed to advance precision medicine by pioneering microbiome-based technologies that transform cancer care. The company is strategically positioned at the intersection of state-of-the-art DNA sequencing and advanced machine learning algorithms to develop first in class technologies for routine clinical practice. Additionally to the lifestyle product myBioma (www.mybioma.com) for end-customers, the company focuses on the development of medically certified products in the area of gut microbiome and cancer. As safety and health of patients are top priorities, the company has already been repeatedly certified according to ISO 9001 (quality management systems) and ISO 13485 (medical devices). BiomeDx® is worldwide the first microbiome company double ISO-certified.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Austria
2
Frequently asked questions
Who invested in Biome Diagnostics?
Biome Diagnostics has 2 investors on record on gritt.io, 2 mid-stage.
When did Biome Diagnostics last raise funding?
The most recent investment in Biome Diagnostics recorded on gritt.io was in December 2022.
When was Biome Diagnostics founded?
Biome Diagnostics was founded in 2018.
What industry is Biome Diagnostics in?
Biome Diagnostics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Biome Diagnostics based?
Biome Diagnostics is headquartered in Vienna, Austria.